NCT01535261 Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion Status COMPLETED Phase PHASE3
NCT01534182 Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC) Status COMPLETED Phase PHASE4
NCT01532687 Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT01531309 Pharmacokinetics of AGO178 in Participants With Liver Impairment Status COMPLETED Phase PHASE1
NCT01529632 Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01529619 Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors Status COMPLETED Phase PHASE4
NCT01529307 First in Human Trial of TAS266 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01529294 Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01528345 Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Status TERMINATED Phase PHASE2
NCT01528254 VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01528241 Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET) Status COMPLETED Phase PHASE1
NCT01527500 Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT01526889 Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , Status COMPLETED Phase PHASE2
NCT01524783 Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) Status COMPLETED Phase PHASE3
NCT01524341 Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection Status COMPLETED Phase PHASE2
NCT01521715 First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE4
NCT01520922 Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) Status COMPLETED Phase PHASE2
NCT01520103 Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer Status COMPLETED Phase PHASE2